Zhang Ziyuan, Sun Yunchao, Wang Jianmin, Zhang Xin, Guo Na, Niu Shaolong, Ma Zening
Hebei University of Chinese Medicine, Shijiazhuang, 050091, Hebei, China.
Department of Peripheral Vascular Surgery, Hebei Hospital of Traditional Chinese Medicine, Shijiazhuang, 050011, Hebei, China.
Thromb J. 2025 Jun 10;23(1):60. doi: 10.1186/s12959-025-00748-2.
Mycoplasma pneumoniae pneumonia complicated with arterial embolism in children is rare but progresses rapidly, potentially leading to severe limb ischemia and disability. This study reports a case of MPP complicated with upper limb arterial embolism and reviews relevant literature to explore its pathogenesis, treatment strategies, and clinical management principles.
On January 9, 2025, Hebei Provincial Hospital of Traditional Chinese Medicine admitted an Asian male pediatric patient with upper limb arterial embolism. The patient developed acute limb ischemia secondary to Mycoplasma pneumoniae pneumonia and was diagnosed with upper limb arterial embolism. Endovascular thrombectomy was performed, followed by postoperative anticoagulation, anti-infective therapy, and traditional Chinese medicine treatment. After comprehensive management, the ischemic condition of the affected limb significantly improved, with no obvious functional impairment, achieving satisfactory therapeutic outcomes.
The risk of thrombosis in children with Mycoplasma pneumoniae pneumonia is often overlooked by clinicians. Due to its rapid progression and potentially severe consequences, early identification of thrombotic risk is crucial. A multidisciplinary approach should be adopted to determine the most appropriate treatment strategy for each patient, aiming to improve prognosis and reduce the risk of disability.
儿童支原体肺炎合并动脉栓塞较为罕见,但病情进展迅速,可能导致严重的肢体缺血和残疾。本研究报告1例支原体肺炎合并上肢动脉栓塞的病例,并回顾相关文献,探讨其发病机制、治疗策略及临床管理原则。
2025年1月9日,河北省中医院收治1例患有上肢动脉栓塞的亚洲男性儿科患者。该患者继发于支原体肺炎出现急性肢体缺血,被诊断为上肢动脉栓塞。进行了血管内血栓切除术,术后进行抗凝、抗感染治疗及中药治疗。经过综合治疗,患肢缺血状况明显改善,无明显功能障碍,取得了满意的治疗效果。
临床医生常忽视支原体肺炎患儿的血栓形成风险。由于其进展迅速且后果可能严重,早期识别血栓形成风险至关重要。应采用多学科方法为每位患者确定最合适的治疗策略,以改善预后并降低残疾风险。